Trial Profile
Study of PT2385 in combination with immune checkpoint inhibitors in patients with Clear Cell Renal Cell Carcinoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2016
Price :
$35
*
At a glance
- Drugs PT 2385 (Primary)
- Indications Renal cancer
- Focus Adverse reactions
- 21 Apr 2016 New trial record